A Regulatory Stumble: FDA Puts Brakes on Moderna's Flu Vaccine Hopes
A Setback for Moderna's mRNA Flu Vaccine Aspirations
Anavex's European Dream for Blarcamesine Hits a Regulatory Wall
The Long Road to Hope: Anavex's Alzheimer's Drug Hits a Regulatory Wall
Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File